MicroRNAs in Preeclampsia: An Overview of Biomarkers and Potential Therapeutic Targets
International Journal of Molecular Sciences · 11.06.2025 · 26 (12) · 5607
DOI: 10.3390/ijms26125607 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.06.2025. Verfasst von Mihaela Oancea und 8 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Obstetrics and Ginecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Pre-Eclampsia, MicroRNAs, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the “Iuliu Hatieganu” University of Medicine and Pharmacy.
Abstract (Originalsprache)
Preeclampsia (PE) remains a significant obstetric challenge, having complex pathophysiology and limited early diagnostic and therapeutic options. MicroRNAs (miRNAs) have emerged as critical regulators in PE, offering insight into the molecular mechanisms underlying placental dysfunction and impaired maternal adaptation. Differentially expressed miRNAs in both placental tissue and maternal circulation, such as miR-155, play key roles in regulating angiogenesis, trophoblast invasion, and inflammatory pathways, all of which are central to the development of PE. Ongoing investigations increasingly highlight miRNAs as promising non-invasive molecular indicators for the early diagnosis and risk stratification of PE. Furthermore, therapeutic strategies targeting miRNA pathways using mimics or inhibitors show promise in correcting molecular dysfunctions and improving maternal and fetal outcomes. However, clinical translation faces several challenges, including targeted delivery, off-target effects, and the assessment of long-term efficacy. Overall, miRNAs hold significant potential as both diagnostic tools and therapeutic agents, marking a promising direction for improving care in PE pregnancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Department of Obstetrics and Ginecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania.
- Department of Genomics, MEDFUTURE Institute for Biomedical Research, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400610 Cluj-Napoca, Romania.
- Obstetrics and Gynecology I, Mother and Child Department, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Center for Health Outcomes & Evaluation, Splaiul Unirii 45, 030126 Bucharest, Romania.
ORCID-Profile: Ionel-Daniel Nati, Dan Boitor-Borza, Stefan Strilciuc, Adrian Pană
Förderung
- the “Iuliu Hatieganu” University of Medicine and Pharmacy
Zitieren
APA
Oancea, M., Mihu, D., Braicu, C., Isachesku, E., Nati, I. D., Boitor-Borza, D., Diculescu, D. M., Strilciuc, S., & Pană, A. (2025). MicroRNAs in Preeclampsia: An Overview of Biomarkers and Potential Therapeutic Targets. International Journal of Molecular Sciences, 26(12), 5607. https://doi.org/10.3390/ijms26125607
Vancouver
Oancea M, Mihu D, Braicu C, Isachesku E, Nati ID, Boitor-Borza D, et al. MicroRNAs in Preeclampsia: An Overview of Biomarkers and Potential Therapeutic Targets. International Journal of Molecular Sciences. 2025;26(12):5607. doi:10.3390/ijms26125607
BibTeX
@article{Oancea2025,
author = {Oancea, Mihaela and Mihu, Dan and Braicu, Cornelia and Isachesku, Ekaterina and Nati, Ionel-Daniel and Boitor-Borza, Dan and Diculescu, Doru Mihai and Strilciuc, Stefan and Pană, Adrian},
title = {MicroRNAs in Preeclampsia: An Overview of Biomarkers and Potential Therapeutic Targets},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {12},
pages = {5607},
doi = {10.3390/ijms26125607}
}
EUVIMED